GAPDH Blocking Peptide

Catalog no. P-GPDH-121 · Research Use Only

$155 per 250 µg. Ships within 2–3 business days from the U.S.

P-GPDH-121 — affinity-purified Rabbit antibody against GAPDH. Validated for Immunodepletion, Immunocompetition.

Specifications

Catalog numberP-GPDH-121
TargetGAPDH
ApplicationsImmunodepletion, Immunocompetition
ConjugateUnconjugated
ImmunogenSynthetic peptide taken within amino acid region 250-300 on human Glyceraldehyde-3-phosphate dehydrogenase protein.
Size250 µg
Storage-20°C
UniProtP04406

About this target

GAPDH Blocking Peptide is the antigenic blocking peptide for the GAPDH antibody GPDH-101AP. Pre-incubating the antibody with the peptide competes away specific binding, which helps confirm that a signal comes from the intended target. Supplied at 250 µg, for research use only. Catalyzes the conversion of D-glyceraldehyde 3-phosphate (G3P) into 3-phospho-D-glyceroyl phosphate in glycolysis and the reverse reaction in gluconeogenesis. Also shows nitrosylase activity, thereby playing a role in nuclear functions. Modulates the organization and assembly of the cytoskeleton. Facilitates the CHP1-dependent microtubule and membrane associations through its ability to stimulate the binding of CHP1 to microtubules. Subcellular location: Cytoplasm, cytosol. Nucleus. Cytoplasm, perinuclear region. Membrane. Cytoplasm, cytoskeleton. Note=Translocates to the nucleus following S-nitrosylation and interaction with SIAH1, which contains a nuclear localization signal.

Documents

Related products

FabGennix International, Inc., 9191 Kyser Way, Frisco, TX 75033. For research use only. Not for diagnostic or therapeutic use.